Papers

18

Total Citations

349

H-Index

10

About

Dr. Maximilian C. Kriegmair is a leading urologic surgeon whose research centers on advancing minimally invasive surgical techniques, particularly robotic-assisted procedures for renal and prostate cancer. His major contributions include landmark comparative studies demonstrating the safety and efficacy of robotic partial nephrectomy (RAPN) for complex cases, such as completely endophytic renal tumors, where his work showed comparable trifecta outcomes to open surgery. He led the ROBOCOP II trial, the first randomized controlled feasibility study comparing RAPN to open partial nephrectomy, and authored a seminal systematic review on renorrhaphy suture techniques (90 citations). Dr. Kriegmair has also pioneered lymphocele prevention through the randomized PELYCAN trial, evaluating peritoneal flap techniques during robotic prostatectomy. His meta-analyses on robotic simple prostatectomy versus endoscopic enucleation and on radical cystectomy approaches have shaped clinical decision-making. With over 300 citations across his top-cited works, Dr. Kriegmair’s research provides high-level evidence that defines best practices in robotic urologic oncology, directly improving perioperative outcomes and expanding the boundaries of what is achievable with minimally invasive surgery.

Research Focus

Key Achievements

10
H-Index
18
Papers
349
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Suture techniques during laparoscopic and robot‐assisted partial nephrectomy: a systematic review and quantitative synthesis of peri‐operative outcomes
90 citations · 2018
📈 Most Prolific Year: 2022 (5 Papers)
🤝 Key Collaborators: 94
🏛 Institutions: University Medical Centre Mannheim, Heidelberg University, University Hospital Heidelberg

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago